Skip to main content
. 2016 Jan 5;18(8):750–761. doi: 10.1111/jch.12746

Table 1.

Logistic Regression Model With Significant Predictors of Hypertension Prevalence, NHANES 1999–2012 (N=27,858)

Beta Coefficient SE P Value Predicted Hypertension Prevalence Proportion of the Population
% SE
Intercept −2.0671 0.0622 <.001
Sex
Male referent 33.6 0.7 45.5
Female −0.6636 0.0761 <.001 32.0 0.6 54.5
Age group, y
18–44 referent 15.0 0.5 46.1
45–64 1.1457 0.0736 <.001 37.9 0.8 35.3
65–74 1.7613 0.0951 <.001 54.8 1.1 10.7
75+ 1.9776 0.0888 <.001 62.1 1.2 8.0
Race/ethnicity
Non‐Hispanic white referent 32.0 0.6 73.0
Non‐Hispanic black 0.6824 0.0513 <.001 42.6 0.8 10.6
Hispanic −0.2553 0.0607 <.001 28.3 0.8 11.2
Other 0.1056 0.0881 .233 33.5 1.4 5.2
Education
<College graduate referent 34.8 0.5 62.9
College graduate −0.2405 0.0483 <.001 31.0 0.8 25.5
<25 years of age −1.5740 0.1554 <.001 14.5 1.5 11.6
Household income
<$75k referent 34.0 0.6 61.8
≥$75k −0.1251 0.0659 .060 32.1 1.0 15.8
Missing income −0.2679 0.0493 <.001 30.0 0.7 22.4
Obesitya
Yes 0.8166 0.0438 <.001 40.9 0.7 33.6
No referent 28.2 0.6 66.4
High cholesterolb
Yes 0.5109 0.0419 <.001 37.6 0.8 32.0
No referent 29.7 0.5 68.0
History of cardiovascular diseasec
Yes 0.4500 0.0778 <.001 39.1 1.2 7.8
No referent 32.2 0.6 92.3
Diabetesd
Yes 0.5824 0.0639 <.001 41.0 1.0 9.2
No referent 31.8 0.5 90.8
Chronic kidney diseasee
Yes 0.7462 0.0517 <.001 42.8 1.0 15.4
No referent 30.8 0.5 84.6
Sex and age group interaction, y
Male, 18–44 referent 19.1 0.7 21.1
Male, 45–64 referent 38.5 1.1 16.2
Male, 65–74 referent 51.2 1.7 4.9
Male, 75+ referent 55.7 1.5 3.3
Female, 18–44 referent 11.6 0.6 25.0
Female, 45–64 0.6079 0.1038 <.001 37.4 1.0 19.0
Female, 65–74 0.9821 0.1279 <.001 57.8 1.4 5.8
Female, 75+ 1.2508 0.1249 <.001 67.4 1.5 4.7

Abbreviations: NHANES, National Health and Nutrition Examination Survey; SE, standard error. aBody mass index ≥30.0 kg/m2. bReported being told by a doctor that they had high cholesterol or classified as such according to the Third Report of the National Cholesterol Education Program Adult Treatment Panel III with a total cholesterol ≥240 mg/dL. cReported having a history of coronary heart disease, myocardial infarction, stroke, or angina. dReported being told by a doctor that they had diabetes. eHad an estimated glomerular filtration rate <60 mL/min per 1.73 m2 or albumin‐to‐creatinine ratio ≥30 mg/g.